X0306 4 2019-01-15 0 0001560258 electroCore, Inc. ECOR 0001737616 Errico Joseph P 150 ALLEN ROAD, SUITE 201 BASKING RIDGE NJ 07920 1 1 1 0 See Remarks Common Stock 2019-01-15 4 S 0 22349 4.90 D 610000 D Common Stock 2019-01-16 4 S 0 19810 4.89 D 590190 D Common Stock 2019-01-17 4 S 0 7841 4.84 D 582349 D Common Stock 69444 I Via Errico 2010 Dynasty Trust Common Stock 55729 I Via children Common Stock 111318 I Via Core Ventures 2010, LLC Common Stock 50498 I Via 2010 Core Investment Partners, LLC Common Stock 419789 I Via Core Ventures II, LLC Common Stock 15576 I Via Core Ventures IV, LLC Common Stock 25473 I Via ECNG, LLC Common Stock 382607 I Via NeuroCore Investment Partners, LLC These shares were sold pursuant to the Reporting Person's written trading plan pursuant to Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.70 to $5.11 per share. The Reporting Person undertakes to provide to electroCore, Inc., any security holder of electroCore, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased by it at each separate price on January 15, 2019. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.81 to $4.97 per share. The Reporting Person undertakes to provide to electroCore, Inc., any security holder of electroCore, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased by it at each separate price on January 16, 2019. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.68 to $4.95 per share. The Reporting Person undertakes to provide to electroCore, Inc., any security holder of electroCore, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased by it at each separate price on January 17, 2019. Chief Science & Strategy Officer /s/ John L. Cleary, II, attorney-in-fact 2019-01-17